{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T16:37:12Z","timestamp":1792773432041,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Europe"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.lanepe.2026.101830","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T11:46:42Z","timestamp":1787744802000},"page":"101830","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The effect of HPV vaccination on precancerous lesions and invasive cervical cancer in a low-vaccination-coverage setting in Germany: a retrospective cohort analysis"],"prefix":"10.1016","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-4525-4097","authenticated-orcid":false,"given":"Gifty","family":"Baffour Awuah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Fett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunther","family":"Schauberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0650-4333","authenticated-orcid":false,"given":"Vanesa","family":"Osmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Tauscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"R\u00f6bl-Mathieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Kiechle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3523-1362","authenticated-orcid":false,"given":"Stefanie J.","family":"Klug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.lanepe.2026.101830_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.lanepe.2026.101830_bib2","series-title":"Cancer in Germany 2021 \u2013 2023","year":"2026"},{"key":"10.1016\/j.lanepe.2026.101830_bib3","series-title":"Biological agents: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans","year":"2012"},{"key":"10.1016\/j.lanepe.2026.101830_bib4","series-title":"Global Strategy to Accelerate the Elimination of Cervical Cancer as a Public Health Problem Geneva","year":"2020"},{"issue":"50","key":"10.1016\/j.lanepe.2026.101830_bib5","first-page":"645","article-title":"Human papillomavirus vaccines: WHO position paper (2022 update)","volume":"97","year":"2022","journal-title":"Wkly Epidemiol Rec"},{"issue":"Rr-05","key":"10.1016\/j.lanepe.2026.101830_bib6","first-page":"1","article-title":"Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"63","author":"Markowitz","year":"2014","journal-title":"MMWR Recomm Rep"},{"issue":"12","key":"10.1016\/j.lanepe.2026.101830_bib7","first-page":"97","article-title":"[Statement of the German Standing Committee on Vaccination (STIKO) at the Robert Koch Institute: Vaccination against human papilloma viruses (HPV) for girls aged 12 to 17 - recommendation and justification]","year":"2007","journal-title":"Epidemiol Bull"},{"issue":"35","key":"10.1016\/j.lanepe.2026.101830_bib8","first-page":"341","article-title":"[Update in the current recommendations of the German Standing Committee on Vaccination (STIKO) at the RKI from August 2014]","year":"2014","journal-title":"Epidemiol Bull"},{"issue":"26","key":"10.1016\/j.lanepe.2026.101830_bib9","first-page":"233","article-title":"[Background paper for recommending HPV vaccination for boys ages 9 to 14]","year":"2018","journal-title":"Epidemiol Bull"},{"key":"10.1016\/j.lanepe.2026.101830_bib10","series-title":"Human Papillomavirus (HPV) Immunisation Data","year":"2024"},{"key":"10.1016\/j.lanepe.2026.101830_bib12","unstructured":"Public Health Agency of Sweden. Vaccination programmes. https:\/\/www.folkhalsomyndigheten.se\/the-public-health-agency-of-sweden\/communicable-disease-control\/vaccinations\/vaccination-programmes\/. Accessed July 7, 2024."},{"issue":"50","key":"10.1016\/j.lanepe.2026.101830_bib16","first-page":"3","article-title":"[Immunisation coverage in Germany]","author":"Rieck","year":"2025","journal-title":"Epidemiol Bull"},{"issue":"12","key":"10.1016\/j.lanepe.2026.101830_bib17","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1007\/s00103-018-2835-7","article-title":"[Cervical cancer screening in Germany]","volume":"61","author":"Bujan Rivera","year":"2018","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"10.1016\/j.lanepe.2026.101830_bib18","series-title":"[Directive for Organized Cancer Screening Programs and Cancer Screening Guideline: Program for the Early Detection of Cervical Cancer]","year":"2018"},{"issue":"12","key":"10.1016\/j.lanepe.2026.101830_bib19","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1007\/s00103-018-2842-8","article-title":"[Cancer screening examinations in Germany: availability and uptake]","volume":"61","author":"Starker","year":"2018","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"issue":"5","key":"10.1016\/j.lanepe.2026.101830_bib20","article-title":"Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors","volume":"5","author":"Arbyn","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"14","key":"10.1016\/j.lanepe.2026.101830_bib21","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1056\/NEJMoa1917338","article-title":"HPV vaccination and the risk of invasive cervical cancer","volume":"383","author":"Lei","year":"2020","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.lanepe.2026.101830_bib22","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1093\/jnci\/djab080","article-title":"Real-world effectiveness of human papillomavirus vaccination against cervical cancer","volume":"113","author":"Kjaer","year":"2021","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"10.1016\/j.lanepe.2026.101830_bib23","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/jnci\/djad263","article-title":"Invasive cervical cancer incidence following bivalent human papillomavirus vaccination: a population-based observational study of age at immunization, dose, and deprivation","volume":"116","author":"Palmer","year":"2024","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.lanepe.2026.101830_bib24","article-title":"The effect of bivalent HPV vaccination against invasive cervical cancer and cervical intraepithelial neoplasia grade 3 (CIN3+) in the Netherlands: a population-based linkage study","volume":"54","author":"Middeldorp","year":"2025","journal-title":"Lancet Reg Health Eur"},{"issue":"1","key":"10.1016\/j.lanepe.2026.101830_bib25","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1186\/s12885-022-10214-1","article-title":"HPV vaccination leads to decrease of anogenital warts and precancerous lesions of the cervix uteri in young women with low vaccination rates: a retrospective cohort analysis","volume":"22","author":"Osmani","year":"2022","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.lanepe.2026.101830_bib26","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1186\/s12879-020-05002-w","article-title":"Burden of HPV related anogenital diseases in young women in Germany - an analysis of German statutory health insurance claims data from 2012 to 2017","volume":"20","author":"Reuschenbach","year":"2020","journal-title":"BMC Infect Dis"},{"issue":"13","key":"10.1016\/j.lanepe.2026.101830_bib27","first-page":"415","article-title":"Initial evidence of a possible effect of HPV vaccination on cancer incidence in Germany\u2014focus on cervical cancer","volume":"121","author":"Grieger","year":"2024","journal-title":"Dtsch Arztebl Int"},{"issue":"2","key":"10.1016\/j.lanepe.2026.101830_bib28","first-page":"120","article-title":"[Good practice of secondary data analysis (GPS): guidelines and recommendations]","volume":"77","author":"Swart","year":"2015","journal-title":"Gesundheitswesen"},{"issue":"2","key":"10.1016\/j.lanepe.2026.101830_bib29","first-page":"7","article-title":"Sexual and contraceptive behaviour of young adults in Germany - results from KiGGS wave 2","volume":"7","author":"Hintzpeter","year":"2022","journal-title":"J Health Monit"},{"issue":"6","key":"10.1016\/j.lanepe.2026.101830_bib30","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1093\/cid\/cix475","article-title":"Age of acquiring causal human papillomavirus (HPV) infections: leveraging simulation models to explore the natural history of HPV-induced cervical cancer","volume":"65","author":"Burger","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"28","key":"10.1016\/j.lanepe.2026.101830_bib31","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000029329","article-title":"Association of human papillomavirus vaccination with cervical cancer screening: a systematic review and meta-analysis","volume":"101","author":"Ssentongo","year":"2022","journal-title":"Medicine (Baltim)"},{"issue":"4","key":"10.1016\/j.lanepe.2026.101830_bib32","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/ijc.27713","article-title":"Differences in human papillomavirus type distribution in high-grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe","volume":"132","author":"Tjalma","year":"2013","journal-title":"Int J Cancer"},{"issue":"10451","key":"10.1016\/j.lanepe.2026.101830_bib33","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0140-6736(24)01097-3","article-title":"Causal attribution of human papillomavirus genotypes to invasive cervical cancer worldwide: a systematic analysis of the global literature","volume":"404","author":"Wei","year":"2024","journal-title":"Lancet"},{"issue":"67","key":"10.1016\/j.lanepe.2026.101830_bib34","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/jncimonographs\/lgae042","article-title":"A prospective cohort study comparing efficacy of 1 dose of quadrivalent human papillomavirus vaccine to 2 and 3 doses at an average follow up of 12 years postvaccination","volume":"2024","author":"Malvi","year":"2024","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"12","key":"10.1016\/j.lanepe.2026.101830_bib35","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1038\/s41591-023-02658-0","article-title":"Durability of single-dose HPV vaccination in young Kenyan women: randomized controlled trial 3-year results","volume":"29","author":"Barnabas","year":"2023","journal-title":"Nat Med"},{"issue":"10","key":"10.1016\/j.lanepe.2026.101830_bib36","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1093\/jnci\/djaa011","article-title":"Evaluation of durability of a single dose of the bivalent HPV vaccine: the CVT trial","volume":"112","author":"Kreimer","year":"2020","journal-title":"J Natl Cancer Inst"},{"issue":"9","key":"10.1016\/j.lanepe.2026.101830_bib37","first-page":"388","article-title":"[HPV vaccination: highly effective cancer prevention, still underutilized]","author":"R\u00f6bl-Mathieu","year":"2025","journal-title":"Bayer Aztebl"},{"issue":"4","key":"10.1016\/j.lanepe.2026.101830_bib38","first-page":"82","article-title":"Utilization of outpatient medical care in Germany","volume":"2","author":"Pr\u00fctz","year":"2017","journal-title":"J Health Monit"}],"container-title":["The Lancet Regional Health - Europe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666776226002425?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666776226002425?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T15:07:51Z","timestamp":1792768071000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666776226002425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":34,"alternative-id":["S2666776226002425"],"URL":"https:\/\/doi.org\/10.1016\/j.lanepe.2026.101830","relation":{},"ISSN":["2666-7762"],"issn-type":[{"value":"2666-7762","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of HPV vaccination on precancerous lesions and invasive cervical cancer in a low-vaccination-coverage setting in Germany: a retrospective cohort analysis","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Europe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanepe.2026.101830","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101830"}}